Survival Clinical Trials in Shanghai
4 recruitingShanghai, China
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
TreatmentSurvivalClassical Hodgkin Lymphoma+6 more
Children's Cancer Group, China96 enrolled1 locationNCT06563245
Recruiting
Phase 2
Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies
Disease Free Survival
Shanghai Jiao Tong University School of Medicine61 enrolled2 locationsNCT05436561
Recruiting
A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University74 enrolled1 locationNCT05940441
Recruiting
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
SurgeryNeoplasmsRadiotherapy+2 more
Fudan University500,000 enrolled1 locationNCT04996732